09:57 AM EDT, 06/23/2025 (MT Newswires) -- (Updates to add recent share price movement in the headline and first paragraph.)

Hims & Hers Health ( HIMS ) shares were down more than 26% in recent Monday trading, while Novo Nordisk ( NVO ) stock was nearly 6% lower after Novo Nordisk ( NVO ) said it has halted its collaboration with Hims & Hers on the sale of weight loss drugs, including Wegovy.

The two companies launched a collaboration in April to bundle Wegovy through Hims & Hers' telehealth platform.

But Novo Nordisk ( NVO ) said direct access to the drug would no longer be available through Hims & Hers Health ( HIMS ) because the company "has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk."

Hims & Hers did not immediately reply to MT Newswires' request for comment.

Price: 69.59, Change: -4.18, Percent Change: -5.67